A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults

Key Inclusion Criteria: * Must agree to adhere to the protocol-specified contraception requirements. * Body mass index of 18.0 to 32.0 kilograms (kg)/meter squared as measured at screening. * Weight ≥50 kg at screening. Key Exclusion Criteria: * Any history of hypersensitivity to delafloxacin or any other fluoroquinolones or previous history of tendon disorders related to fluoroquinolone administration. * History of clinically significant cardiovascular, renal, hepatic, respiratory, or particularly gastrointestinal disease. * Participant has a medical condition that may adversely affect taste or smell activity including but not limited to mouth ulcers, significant gum disease, and respiratory and/or sinus infection or cold. * Clinically significant abnormal clinical chemistry, hematology or urinalysis as judged by the Investigator. Participants with Gilbert's Syndrome are not allowed. * Participants who do not agree to eat a high-fat breakfast. Note: Other inclusion/exclusion criteria may apply.